Why is Aristo Bio-Tech falling/rising?

As of 11-Jul, Aristo Bio-Tech & Lifescience Ltd is experiencing a slight decline in its stock price, currently at 131.00, reflecting a change of -0.1, or -0.08%. The stock has underperformed in the short term, with a 1-week return of -7.75%, while it has shown a positive performance over the past month with an increase of 11.02%. However, the stock's year-to-date performance is down by 1.50%, despite a strong annual return of 27.06%. Today's price summary indicates that the stock has outperformed its sector by 0.5%, but there is a notable decline in investor participation, with delivery volume falling by 73.68% compared to the 5-day average. Unfortunately, there are no available positive or negative factors to further explain the stock's recent movement.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has only decreased by 1.22% over the past week. While the stock has outperformed the sector today, the significant drop in delivery volume suggests a lack of investor confidence, which could be contributing to the stock's decline. The overall market has shown resilience with a year-to-date increase of 6.37%, indicating that the broader market conditions are relatively stable, yet Aristo Bio-Tech's performance remains under pressure in comparison to both the benchmark and its recent historical performance.